MeSH tree: C17.800
A significant number of cancer patients—particularly those with more advanced cancers who are more likely to receive care at community hospitals, safety net hospitals, and rural medical centers—may have incomplete case information ...
May 14, 2026
0
2
When Mayo Clinic researchers sequenced the genomes of 484 seemingly healthy adults, they found that about 13% carried a serious, previously unrecognized genetic risk—conditions those patients did not know about and that standard ...
May 14, 2026
0
3
Diabetic ulcers, which occur in patients with diabetes, are dangerous complications that can lead to amputation if the treatment window is missed. A research team has developed a wireless, battery-free optoelectronic multi-modal ...
May 14, 2026
0
3
Friendly skin bacteria could hold the key to stopping eczema in its tracks, according to a breakthrough by a team of UK and Japanese scientists. Their new study reveals harmless microbes living on our skin release powerful ...
May 14, 2026
0
11
A study, led by experts at the University of Nottingham, has found that persistent and distressing upper gut symptoms experienced by people with hypermobile Ehlers-Danlos syndrome (hEDS), are not due to structural problems ...
May 13, 2026
0
4
Creativity and curiosity have always been central to the work of Joshua Moreau, Ph.D., an immunologist whose work at Oregon Health & Science University sits at the intersection of harnessing the immune system; delving into ...
May 8, 2026
0
3
Researchers at the Johns Hopkins Kimmel Cancer Center and the Telomere Clinic at Johns Hopkins have identified a genetic syndrome in which unusually long telomeres—the protective caps at the ends of chromosomes—allow immune ...
May 7, 2026
0
9
Involving a collaboration with 118 investigators contributing from 89 institutions, scientists from Queen Mary University of London's Precision Healthcare University Research Institute and Berlin Institute of Health (BIH) ...
May 6, 2026
0
3
Researchers at The University of Texas MD Anderson Cancer Center and The University of Texas at Austin have identified specific blood-based genomic biomarkers that distinguish inflammatory breast cancer from other subtypes, ...
May 6, 2026
0
4
The U.S. Food and Drug Administration has approved Sanofi and Regeneron's Dupixent (dupilumab) for the treatment of children (aged 2 to 11 years) with chronic spontaneous urticaria (CSU).
May 5, 2026
0
5
